677A

REDISOLV 14 STICK

REDISOLV 14 STICK

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

REDISOLV

Description
Class IIa medical device.
Sachets of liquid product useful for correct intestinal function and for the treatment of symptoms associated with irritable bowel syndrome.
It promotes the normalization of intestinal bacterial flora, reduces abdominal swelling, abdominal pain and cramps.

How to use
Take 1 sachet daily. The dosage can be increased to 2 sachets daily. The product can be taken directly from the sachet or diluted in water or other beverages (juices, yogurt). The recommended duration of treatment is 4 weeks (28 days). If after this period there is no significant improvement in symptoms, consult your doctor.
Before a scheduled surgery, it is advisable to stop treatment for at least 2 weeks.

Components
Partially hydrolyzed guar gum and simethicone; excipients: water, vegetable glycerin, sucralose, citric acid, pear flavoring, potassium sorbate, sodium benzoate, polysorbate 80, sucrose esters.

Warnings
The medical device may delay or reduce the absorption of medications and/or dietary supplements taken simultaneously. In any case, it is recommended to separate the product from medications or dietary supplements by at least 2 hours.
Use of the device is contraindicated in cases of hiatal hernia, esophageal stricture, or intestinal obstruction. The product may interfere with the effectiveness of some diagnostic reagents, such as guaiac gum. Do not use if you have a known hypersensitivity to the product, any of its components, simenticone, or guar gum.
Furthermore, if you are taking oral contraceptives, thyroid medications, or thyroid hormones, and antibiotics at the same time, take Redisolv only after consulting your doctor. The product's components have hypoglycemic effects that may be associated with those of antidiabetic medications; therefore, diabetic patients should consult their doctor before taking the product.
Do not use this product on children under 12 years of age. If you are pregnant or breastfeeding, use only if clearly needed and after consulting your doctor.
It is recommended not to take larger quantities than indicated, as higher doses may cause the onset of unexpected adverse effects.
Do not use for more than 30 consecutive days; if symptoms persist, consult your doctor. Do not use if you have an intolerance to the product.

Conservation
Do not use after the expiration date indicated on the package. The expiration date refers to the product in its intact packaging, stored properly.
Store in a cool, dry place, away from sources of light and heat: open the sachet only before taking it.
Do not use if pouch is damaged.
Store the product at a temperature not exceeding 25°C.

Format
14 sachets of 30 ml.

677A

REDISOLV 14 STICK

REDISOLV 14 STICK

MINSAN code: 985499995
EAN Code: 8050538052295
Previous price: €21,36
Regular price €21,36
Regular price €21,70 Sale price €21,36
-1% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.